Literature DB >> 7585543

Biallelic inactivation of the APC gene in hepatoblastoma.

H Kurahashi1, K Takami, T Oue, T Kusafuka, A Okada, A Tawa, S Okada, I Nishisho.   

Abstract

Familial adenomatous polyposis (FAP) is an inherited disorder caused by germline mutation of the adenomatous polyposis coli (APC) gene. Increased risk of hepatoblastoma (HBL) in FAP kindreds has been reported. To determine whether inactivation of the APC gene plays a role in development of HBL, 13 sporadic infantile hepatic tumors were analyzed for genetic alterations in the APC gene. A PCR-mediated RNase protection analysis was performed to detect subtle genetic alterations in the mutation cluster region and in exons 3 and 4 of the APC gene. The results showed that a G to T transversion at the splice acceptor site of the intron 3-exon 4 junction had occurred in one HBL. Sequence analysis of normal tissue of the patient proved the mutation to be germinal. Southern blot analysis at the APC locus revealed that the tumor had lost the opposite allele and was isodisomic at this locus. RNA analysis indicated that the tumor contained only the small APC transcript, from which exon 4 was entirely absent. Since abnormal splicing causes termination due to frameshift, it was hypothesized that only the truncated APC protein was expressed in this tumor. These findings suggest that inactivation of the APC gene is closely related to tumorigenesis of HBLs in FAP patients.

Entities:  

Mesh:

Year:  1995        PMID: 7585543

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.

Authors:  W Hartmann; A Waha; A Koch; C G Goodyer; S Albrecht; D von Schweinitz; T Pietsch
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.

Authors:  F M Giardiello; G M Petersen; J D Brensinger; M C Luce; M C Cayouette; J Bacon; S V Booker; S R Hamilton
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

3.  Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets.

Authors:  Masahiro Sekiguchi; Masafumi Seki; Tomoko Kawai; Kenichi Yoshida; Misa Yoshida; Tomoya Isobe; Noriko Hoshino; Ryota Shirai; Mio Tanaka; Ryota Souzaki; Kentaro Watanabe; Yuki Arakawa; Yasuhito Nannya; Hiromichi Suzuki; Yoichi Fujii; Keisuke Kataoka; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Teppei Shimamura; Yusuke Sato; Aiko Sato-Otsubo; Shunsuke Kimura; Yasuo Kubota; Mitsuteru Hiwatari; Katsuyoshi Koh; Yasuhide Hayashi; Yutaka Kanamori; Mureo Kasahara; Kenichi Kohashi; Motohiro Kato; Takako Yoshioka; Kimikazu Matsumoto; Akira Oka; Tomoaki Taguchi; Masashi Sanada; Yukichi Tanaka; Satoru Miyano; Kenichiro Hata; Seishi Ogawa; Junko Takita
Journal:  NPJ Precis Oncol       Date:  2020-07-07

Review 4.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

5.  Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.

Authors:  S C Abraham; T T Wu; D S Klimstra; L S Finn; J H Lee; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Hepatocellular adenoma associated with familial adenomatous polyposis coli.

Authors:  Keisuke Inaba; Takanori Sakaguchi; Kiyotaka Kurachi; Hiroki Mori; Hong Tao; Toshio Nakamura; Yasuo Takehara; Satoshi Baba; Masato Maekawa; Haruhiko Sugimura; Hiroyuki Konno
Journal:  World J Hepatol       Date:  2012-11-27

7.  Genetic and clinical characterisation of familial adenomatous polyposis: a population based study.

Authors:  A-L Moisio; H Järvinen; P Peltomäki
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

8.  Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Authors:  S Colnot; T Decaens; M Niwa-Kawakita; C Godard; G Hamard; A Kahn; M Giovannini; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

Review 9.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

Review 10.  Alternative splicing within the Wnt signaling pathway: role in cancer development.

Authors:  B Sumithra; Urmila Saxena; Asim Bikas Das
Journal:  Cell Oncol (Dordr)       Date:  2016-01-13       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.